FIDSON Stock Overview
Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Fidson Healthcare Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦15.75 |
| 52 Week High | ₦19.20 |
| 52 Week Low | ₦9.30 |
| Beta | 0.029 |
| 1 Month Change | -0.94% |
| 3 Month Change | -6.25% |
| 1 Year Change | 68.45% |
| 3 Year Change | 228.13% |
| 5 Year Change | 276.63% |
| Change since IPO | 450.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| FIDSON | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | -0.8% |
| 1Y | 68.4% | 22.4% | 122.8% |
Return vs Industry: FIDSON exceeded the NG Pharmaceuticals industry which returned 22.4% over the past year.
Return vs Market: FIDSON underperformed the NG Market which returned 122.8% over the past year.
Price Volatility
| FIDSON volatility | |
|---|---|
| FIDSON Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in NG Market | 10.9% |
| 10% least volatile stocks in NG Market | 4.1% |
Stable Share Price: FIDSON has not had significant price volatility in the past 3 months.
Volatility Over Time: FIDSON's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 650 | Fidelis Ayebae | fidson.com |
Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables.
Fidson Healthcare Plc Fundamentals Summary
| FIDSON fundamental statistics | |
|---|---|
| Market cap | ₦36.15b |
| Earnings (TTM) | ₦3.28b |
| Revenue (TTM) | ₦60.53b |
11.0x
P/E Ratio0.6x
P/S RatioIs FIDSON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FIDSON income statement (TTM) | |
|---|---|
| Revenue | ₦60.53b |
| Cost of Revenue | ₦36.96b |
| Gross Profit | ₦23.57b |
| Other Expenses | ₦20.29b |
| Earnings | ₦3.28b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.43 |
| Gross Margin | 38.95% |
| Net Profit Margin | 5.42% |
| Debt/Equity Ratio | 95.2% |
How did FIDSON perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield38%
Payout RatioDoes FIDSON pay a reliable dividends?
See FIDSON dividend history and benchmarks| Fidson Healthcare dividend dates | |
|---|---|
| Ex Dividend Date | Jun 19 2024 |
| Dividend Pay Date | Jul 05 2024 |
| Days until Ex dividend | 35 days |
| Days until Dividend pay date | 51 days |
Does FIDSON pay a reliable dividends?
See FIDSON dividend history and benchmarks